A dual colour dual fusion fluorescence in situ hybridisation study on the genesis of complex variant translocations in chronic myelogenous leukaemia

Oncology Reports

Volumn 19, Issue 5, 2008, Pages 1181-1184

  So, Chi Chiu ^a   Wan, Thomas Shek Kong ^a   Yip, Sze Fai ^a   Chan, Li Chong ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

9q34 deletion; Chinese; Chronic myelogenous leukaemia; Cytogenetics; Variant

Indexed keywords

BCR ABL PROTEIN; FLUORESCENT DYE;

ARTICLE; CHROMOSOME 14Q; CHROMOSOME 17Q; CHROMOSOME 1Q; CHROMOSOME ANALYSIS; CHROMOSOME BREAKAGE; CHROMOSOME COMPLEX VARIANT TRANSLOCATION; CHROMOSOME TRANSLOCATION; CHROMOSOME VARIANT; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; DUAL COLOUR DUAL FLUORESCENCE IN SITU HYBRIDIZATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE FUSION; GENE LOSS; HUMAN; HUMAN CELL; KARYOTYPE 46,XX; KARYOTYPE 46,XY; PRIORITY JOURNAL; CHINA; CHROMOSOME 22; CHROMOSOME 9; CHROMOSOME BANDING PATTERN; ETHNOLOGY; GENE TRANSLOCATION; GENETICS; INSTRUMENTATION; KARYOTYPING; METHODOLOGY; NUCLEOTIDE SEQUENCE;

CHINA; CHROMOSOME BANDING; CHROMOSOMES, HUMAN, PAIR 22; CHROMOSOMES, HUMAN, PAIR 9; CYTOGENETIC ANALYSIS; DNA MUTATIONAL ANALYSIS; FLUORESCENT DYES; FUSION PROTEINS, BCR-ABL; GENE DELETION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; TRANSLOCATION, GENETIC;

EID: 47549114688     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.19.5.1181     Document Type: Article

References (14)

1. Aoun P, Wiggins M, Pickering D, Foran J, Rasheed H, Pavletic, SZ and Sanger W: Interphase fluorescence in situ hybridization studies for the detection of 9q34 deletions in chronic myelogenous leukemia: a practical approach to clinical diagnosis. Cancer Genet Cytogenet 154: 138-143, 2004.
2. Fisher AM, Strike P, Scott C and Moorman AV: Breakpoints of variant 9;22 translocations in chronic myeloid leukemia locate preferentially in the CG-richest regions of the genome. Genes Chromosomes Cancer 43: 383-389, 2005.
3. Yehuda O, Abeliovich D, Ben-Neriah S, Sverdlin I, Cohen R, Varadi G, Orr R, Ashkenazi YJ, Heyd J, Lugassy G and Ben Yehuda D: Clinical implications of fluorescence in situ hybridization analysis in 13 chronic myeloid leukemia cases: Ph-negative and variant Ph-positive. Cancer Genet Cytogenet 114: 100-107, 1999.
4. Calabrese G, Stuppia L, Franchi PG, Peila R, Morizio E, Liberati AM, Spadano A, Di Lorenzo R, Donti E, Antonucci A and Palka G: Complex translocations of the Ph chromosome and Ph negative CML arise from similar mechanisms, as evidenced by FISH analysis. Cancer Genet Cytogenet 78: 153-159, 1994.
5. Reid AG, Huntly BJ, Grace C, Green AR and Nacheva EP: Survival implications of molecular heterogeneity in variant Philadelphia-positive chronic myeloid leukaemia. Br J Haematol 121: 419-427, 2003.
6. Gorusu M, Benn P, Li Z and Fang M: On the genesis and prognosis of variant translocations, in chronic myeloid leukemia. Cancer Genet Cytogenet 173: 97-106, 2007.
7. Sinclair PB, Nacheva EP, Leversha M, Telford N, Chang J, Reid A Bench A, Champion K, Huntly B and Green AR: Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia. Blood 95: 738-743, 2000.
8. Cohen N, Rozenfeld-Granot G, Hardan I, Brok-Simoni F, Amariglio N, Rechavi G and Trakhtenbrot L: Subgroup of patients with Philadelphia-positive chronic myelogenous leukemia characterised by a deletion of 9q proximal to ABL gene: expression profiling, resistance to interferon therapy, and poor prognosis. Cancer Genet Cytogenet 128: 114-119, 2001.
9. Huntly BJ, Reid AG, Bench AJ, Campbell LJ, Telford N, Shepherd P, Szer J, Prince HM, Turner P, Grace C, Nacheva EP and Green AR: Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia. Blood 98: 1732-1738, 2001.
10. Kolomietz E, Al-Maghrabi J, Brennan S, Karaskova J, Minkin S, Lipton J and Squire JA: Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis. Blood 97: 3581-3588, 2001.
11. Wan TS, Ma SK, Ho MY, Chan LC, Yip SF, Wong LG and Yeung YM: Cytogenetic biclonality in polycythemia vera: unusual and unrelated clones. Cancer Genet Cytogenet 131: 86-89, 2001.
12. Wan TS, So CC, Hui KC, Yip SF, Ma ES and Chan LC: Diagnostic utility of dual fusion PML/RARalpha translocation DNA probe (D-FISH) in acute promyelocytic leukemia. Oncol Rep 17: 799-805, 2007.
13. Reid AG and Nacheva EP: Genesis of derivative chromosome 9 deletions in chronic myeloid leukemia. Genes Chromosomes Cancer 43: 223-224, 2005.
14. + chronic myeloid leukemia. Zhonghua Xue Ye Xue Za Zhi 27: 183-186, 2006.